Paradigm Biopharmaceuticals Ltd.ASX: PAR

Presentation of phase 2 clinical trial results

Dec 18, 2018 at 3:09 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment